Abstract | PURPOSE OF REVIEW: Over the last several years, novel immunologic pathways pivotal in the development of the pathobiology of psoriasis and psoriatic arthritis (PsA) have been revealed. These discoveries catalyzed a search for new treatment targets resulting in many new therapies that are now available for patients with psoriatic disease. RECENT FINDINGS: SUMMARY:
|
Authors | Christopher T Ritchlin, James G Krueger |
Journal | Current opinion in rheumatology
(Curr Opin Rheumatol)
Vol. 28
Issue 3
Pg. 204-10
(May 2016)
ISSN: 1531-6963 [Electronic] United States |
PMID | 27022911
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Arthritis, Psoriatic
(therapy)
- Biological Factors
(therapeutic use)
- Humans
- Immunotherapy
(methods)
- Psoriasis
(therapy)
|